Koers PT Kalbe Farma Tbk INDONESIA S.E.
Aandelen
KLBF
ID1000096803
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- IDR | - |
Omzet 2024 * | 32.560 mld. 2,05 mld. 1,89 mld. | Omzet 2025 * | 34.951 mld. 2,2 mld. 2,03 mld. | Marktkapitalisatie | 66.839 mld. 4,21 mld. 3,88 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 3.132 mld. 197 mln. 182 mln. | Nettowinst (verlies) 2025 * | 3.496 mld. 220 mln. 203 mln. | EV/omzet 2024 * | 1,94 x |
Nettoliquiditeiten 2024 * | 3.714 mld. 234 mln. 215 mln. | Nettoliquiditeiten 2025 * | 4.587 mld. 289 mln. 266 mln. | EV/omzet 2025 * | 1,78 x |
K/w-verhouding 2024 * |
21,4
x | K/w-verhouding 2025 * |
19,2
x | Werknemers | - |
Dividendrendement 2024 * |
2,28% | Dividendrendement 2025 * |
2,4% | Vrij verhandelbaar | 40,44% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vidjongtius
CEO | Chief Executive Officer | 59 | 01-01-97 |
Chairman | 62 | 01-03-97 | |
Danny Natalies
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Santoso Oen
BRD | Director/Board Member | 59 | 01-01-00 |
Chairman | 62 | 01-03-97 | |
Ronny Hadiana
BRD | Director/Board Member | 52 | 01-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,36% | 694 mld. | |
+30,77% | 593 mld. | |
-1,60% | 371 mld. | |
+20,07% | 331 mld. | |
+6,04% | 290 mld. | |
+14,77% | 239 mld. | |
+9,13% | 209 mld. | |
-3,97% | 209 mld. | |
+9,27% | 169 mld. |
- Beurs
- Aandelen
- Koers KLBF
- Koers KLBF